Amy Welsh serves as Executive at AGILE THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Amy Welsh has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 26, 2024 involved selling 10,125 shares valued at $15.4K.
Amy Welsh currently holds 3,375 shares of AGILE THERAPEUTICS INC (AGRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amy Welsh has been a net neutral trader of AGRX stock. They have purchased $0 and sold $0 worth of shares.
Amy Welsh's most recent insider trade was on Aug 26, 2024, when they sold 10,125 shares at $1.52 per share.
Get notified when new Form 4 filings are submitted
| 3,375 |
| $1.52 |
| Discretionary |
| Jun 28, 2023 | AGRX | $0 | Award | 13,500 | $N/A | Discretionary |